Prevalence of HIV, HCV and other sexually transmitted infections and associated risk behaviours among Spanish and immigrant IDU in Catalonia, Spain
|
|
- Dwayne Anthony
- 5 years ago
- Views:
Transcription
1 Prevalence of HIV, HCV and other sexually transmitted infections and associated risk behaviours among Spanish and immigrant IDU in Catalonia, Spain Folch C, Casabona J, Majó X, Brugal T, Meroño M, González V, and Working group REDAN IHRA s 21st International Conference. Liverpool 26 April 21
2 Where is Catalonia? Barcelona
3 Background In Catalonia foreign population in 2 accounted for less than 3 of the overall population and in 29 that percentage had increased up to 16. We have also observed an increase of the immigrant UDIs which probably have a greater vulnerability to infections due to risk factors such as marginality, social exclusion and low contact with drug and health services. IDUs in Catalonia have still a high HIV prevalence due to the dramatic epidemic in the late 8s. This along with a still high sexual risk behaviour makes knowing the ITS prevalence an important objective in order to decrease HIV and ITS transmission
4 Aims To describe HIV, HCV, Chlamydia trachomatis and Neisseria gonorrhoeae prevalences among IDUs recruited in Catalonia To describe Risk behaviour prevalences related to these infections To compare HIV, HVC and ITS and risk behaviour prevalences between Spanish and Immigrant drug injectors
5 Methodology 748 UDIs recruited from Harm Reduction Services in Catalonia October 28 December 29 Stratified sample by service and country Inclusion criterion: current injectors (Last 6 months) Anonymous interview with a structured questionnaire Collection of biological samples VIH and VHC C. Trachomatis and N. gonorrhoeae
6 Results Sample breakdown by country 7, 6, 58,7 5, 4, 3, 23,5 2, 1, 9,2 6,6,,8,1 1,1
7 Sociodemographics: Spanish n=439 Immigrants n=39 Total p Mean age (DE) 38,5 (7,1) 33,4 (6,9) 36,4 (7,5) <,1 Men 78,1 88, 82,2 <,1 Living in Barcelona 8, 95,1 86,2 <,1 University degrees 1,1 18,3 8,2 <,1 Working situation*: <,1 Working 22,6 24,1 23,2 Unemployed 4,6 56, 47, On Social benefits 28,1 4,9 18,5 Others (begging, stealing...) 8,8 15, 11,3 Ever in prison 67,8 58,9 64,1,12 * Last 6 months
8 Spanish n=439 Immigrants n=39 Total Accommodation (last 6 months) <,1 Own house 49,9 25,6 39,8 Hostel 8,9 15,2 11,5 House with other people 8,9 7,1 8,2 Without a fixed place 19,1 35,3 25,8 Prison 1,8 2,6 2,1 Squatted house 8, 11,3 9,4 Others 3,4 2,9 3,2 Living with (last 6 months):* Alone 29,8 48,9 37,7 <,1 Partner 24,1 23,1 23,7 ns Parents or relatives 35,8 7,8 24,2 <,1 Children 11,4 3,2 8, <,1 Friends or other adults 17,1 32,8 23,6 <,1 p * Non mutually exclusive categories
9 Drug consumption characteristics: Spanish n=439 Immigrants n=39 Total p Ever in treatment 93,6 74,4 85,7 <,1 Meant time of drug injection (DE) 18,1 (8,7) 1,8 (6,7) 15,1 <,1 Most often drug injected** <,1 Heroin 41,3 4,3 4,9 Cocaine 42,5 23,1 34,5 Heroin plus cocaine 16,2 35,7 24, Others* -,9,6 Injecting daily** 43,7 57,6 49,5 <,1 methadone, amphetamine, ketamine, morphine, buprenorphine, LSD, MDMA ** Last 6 months
10 Syringe sharing prevalences P<,1 Spanishs Immigrants ,5 42,9 51,5 Total ,5 19,2 19,4 23,3 22,3 22,9 1 Has ever shared Has accepted syringes (last 6 months) Has passed syringes (last 6 months)
11 Indirect sharing prevalences (Last 6 months)* with a used syringe * p>,5 Spanishs Immigranst Total ,9 5 49,9 54,9 52, Front/backloading Sharing other m aterial
12 Most usual places were syringes are obtained (last 6 months) p<,5 Potentially non sterile sources p<,5 2 1 Buying in pharmacy Most used source for 58 of Spaniards outreach worker NSP Consumption rooms Drug treat. or health facilities Colleagues Partner Drug dealer Most used source for 56 of immigrants Spanish Immigrants
13 Sexual behaviour (Last 6 months): Spanish n=439 Immigrants n=39 Total p Has had sexual intercourse 67,4 72,8 69,7 ns Heterosexual (stable partner) 47,2 5, 48,3 ns With UDI stabel partner* 41,5 44,2 42,6 ns With HIV + stable partner* 24,9 4, 16, <,1 Heterosexual (occasional partners) 31,9 37,9 34,4 ns Sex with clients 8,5 5,8 7,4 ns Homosexual 2,7 3,6 3,1 ns * base: 27 Spanish and 154 immigrants with stable partner
14 Use of condoms by type of sexual partner (Last 6 months) p>, Last sexual intercourse Stable partner Last 6 months sexual interc. p>, Last sexual interc. Occasional partner Last 6 month sexual interc. Spanish Immigrants Total 1 Clients p>,5 Last sexual interc. Last 6 month sexual interc.
15 Use of health services (last 6 months)* ITS centre Family planning centre Hospital Immigrants Spanish Private doctor Drug treatment Prison A&E rooms GP p<,5 * categorías no excluyentes
16 Prevalence of HIV, HVC and STI (biological samples)
17 By country Spanish Immigrants Total 1 HIV p<,1 1 HCV p=, ,2 74,4 74, ,4 34, Chlamydia trachomatis p=,49 1 Neisseria gonorrhoeae p=, ,4 3,6 2,6 2,9,3,7
18 By country and sex Sanish Men Spanish Women Immig. Men Immig. Women 1 HIV 1 HCV ,4 52,6 22,5 21, , ,1 62,2 P<,5 No sign No sign P=,6 3 STI urine ,9 6,3 3,3 8,1 P<,1 No sign
19 Conclusiones There is still a high prevalence of HIV, which is higher among Spanish injectors compared to immigrants. HCV prevalence is very high and similar between the two groups. Immigrants are younger with a shorter injecting career. They have a smaller social network and lower contact with health and drug services apart from harm reduction services. All these may increase their vulnerability to acquire these infections Health and drug treatment services should be more sensitive to the new cultural and ethnic diversity of our society Low prevalence of STI among this population, higher in immigrants. However condom use is low More and better sexual prevention education should be done, especially regarding condom use among stable partners HIV transmission is mainly by risk injecting behaviour We should still expand and improve our harm reduction strategies
20 Acknowledges REDAN WORKING GROUP CEEISCAT: Jordi Casabona, Cinta Folch; Anna Esteve, Alexandra Montoliu; Rafa Muñoz Servei Microbiologia HUGTiP: Victoria González, Elisabeth Bascuñana, Vicenç Ausina Agència de Salut Pública de Barcelona: M. Teresa Brugal, Albert Espelt, Carmen Vecino Sudirecció General de Drogodependències: Xavier Majó, Joan Colom Àmbit Prevenció: Mercè Meroño, Anna Altabas Harm reduction services: Barcelona: Sant Adrià del Besós L Hospitalet de L: Sta Coloma de G Badalona: Reus: Terrassa: Lleida: Constantí: Girona: Àmbit Prevenció (AP), SAPS, Baluard, CAS Vall d Hebrón; El Local Sant Adrià; AEC-Gris ASAUPA M CAS, ARSU AIDE, Alba Arrels, F Mercè Fontanilles Creu Roja IAS Interviewers: Carmen Stanescu; Constanza Daigre; Pau Freixa; Alba Mestres; Silvia Isabel Moreira; Fabio Boccali; Pedro Sánchez; Rosa Kistmacher; Karla Cornejero; Sebastián Riveros; Esteve Lafita; Marc Muñoz; Marta Pardell; Joan Obiols; Concepció Escué
High prevalence and incidence of HIV and HCV among new injecting drug users with a large proportion of migrants Is prevention failing?
High prevalence and incidence of HIV and HCV among new injecting drug users with a large proportion of migrants Is prevention failing? Cinta Folch on behalf of REDAN Study Group Viral Hepatitis Prevention
More informationDifferences by country of origin and by gender among people who inject drugs attending low threshold agencies in Catalonia
Differences by country of origin and by gender among people who inject drugs attending low threshold agencies in Catalonia Folch C 1,3, Casabona J 1,3, Espelt A 2,3, Major X 4, Meroño M 5, Gonzalez V 1,6,
More informationPublic drug policies Catalonia
Public drug policies Catalonia Public Health Agency of Catalonia Xavier Majó Roca Catalonia Barcelona Territory: 32.000 km2 Population: 7.523.000 M Own language and culture 1. What s happened in Catalonia
More informationOne-step screening of active hepatitis C virus infection in the community through dried blood spots
One-step screening of active hepatitis C virus infection in the community through dried blood spots V. Saludes 1,2, C. Folch 2,3, A. Morales-Carmona 4, L. Ferrer 2,3, L. Fernández 2,3, R. Muñoz 2,3, M.
More informationMeasurement of sexual health outcomes among people who inject drugs: pilot study in Catalonia, Spain and Barnaul, Russia
Folch et al. BMC Public Health (2018) 18:187 DOI 10.1186/s12889-018-5065-x RESEARCH ARTICLE Open Access Measurement of sexual health outcomes among people who inject drugs: pilot study in Catalonia, Spain
More informationStrategies of drug users to avoid infection with hepatitis C
With financial support from the Drug Prevention and Information Programme of the European Union Strategies of drug users to avoid infection with hepatitis C Results from five European countries Dr. Heike
More informationHarm reduction among drug users in Spain
Harm reduction among drug users in Spain Luxemburg,, 27 October 21 Dr. José Manuel Arroyo Cobo Deputy Director General of Health in Prisons Ministry of Internal Affairs Dr. Tomás s Hernández ndez Fernández
More informationAUSTRALIAN NSP SURVEY NATIONAL DATA REPORT
Needle Syringe Programs and Harm Reduction Services in Australia AUSTRALIAN NSP SURVEY NATIONAL DATA REPORT - Prevalence of HIV, HCV and injecting and sexual behaviour among NSP attendees The Australian
More informationPrevalence of HIV and risk behaviors among injecting drug users in Tallinn, Estonia in a series of cross-sectional studies
Prevalence of HIV and risk behaviors among injecting drug users in Tallinn, Estonia in a series of cross-sectional studies Sigrid Vorobjov 1, Maris Salekešin 1, Katri Abel-Ollo 1, Anneli Uusküla 2, Don
More informationAdditional North Carolina Projects
Additional North Carolina Projects William Zule, Dr.P.H. www.rti.org RTI International is a trade name of Research Triangle Institute Risk Groups Injecting drug users (IDUs) Non-injecting drug users (non-idus)
More informationPERFORMANCE AND IMAGE ENHANCING DRUGS
PERFORMANCE AND IMAGE ENHANCING DRUGS Injectors access to needle syringe programs Presented at the 2014 National Drug Trends Conference Sydney 20 October 2014 Dr Karen J Chronister Overview Background
More informationImproving Access to Test and Counselling Services for Injection Drug Users: Most Recent Experience from Portugal. Henrique Barros
Improving Access to Test and Counselling Services for Injection Drug Users: Most Recent Experience from Portugal Henrique Barros Ministério da Saúde HIV Testing Knowledge of HIV serostatus has been increasingly
More informationSaskatchewan HIV Strategy: Social Network Approach
Saskatchewan HIV Strategy: Social Network Approach Dr. Johnmark Opondo MHO Provincial Leadership Team (PLT) CATIE Forum: New Science, New Directions in HIV and HCV September 18, 2013 Toronto, Canada A
More informationPoland nationalupdate
Poland nationalupdate 16th October 2014 Annual expert meeting on Drug-related deaths (DRD) and Drug-related infectious diseases (DRID) Estimation of HIV and HCV prevalence among injecting drug users in
More informationHIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications
HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications Don Des Jarlais, Ph.D. Professor of Psychiatry, Icahn School of Medicine at Mount Sinai UNODC 2014
More informationHarm Reduction Database Wales: Needle and Syringe provision
Harm Reduction Database Wales: Needle and Syringe provision 2012-13 Public Health Wales would like to thank all those that contributed to the Harm Reduction Database Wales: NSP service users, NSP staff
More informationNew Brunswick Report on Sexually Transmitted and Blood Borne Infections, 2016
New Brunswick Report on Sexually Transmitted and Blood Borne Infections, 6 Table of Contents. Introduction.... Methodology... 3. Data Limitations.... Definitions used... 3 5. Overview of STBBI epidemiology
More informationhttp://doi.org/0.5/5/5750e0ff6f Perth Gay Community Periodic Survey 00 Conducted by This is a survey of sexual practices of men who have had sex with another man in the last five
More informationThe new German strategy on HIV, Hepatitis B, C and STI, an integrated approach. Ines Perea Ministry of Health, Germany
The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach Ines Perea Ministry of Health, Germany Reasons for a new strategy in 2016 New international agreements (SDG s) Renewed political
More informationSexual Partners and Condom Use Attitude: Qualitative Findings among Injecting Drug Users in Hai Phong, Vietnam
Sexual Partners and Condom Use Attitude: Qualitative Findings among Injecting Drug Users in Hai Phong, Vietnam 2 nd International Conference on HIV/AIDS, STDs & STIs Las Vegas, 2014 Tanvir Ahmed, PhD Candidate
More informationThirty years of harm reduction in the Netherlands HCV elimination ahead?
Thirty years of harm reduction in the Netherlands HCV elimination ahead? Esther Croes, MD PhD Confession 30 years 3 topics: drug use, harm reduction, HCV in 15 minutes IT DOESN T FIT!! 2 Disclosure Esther
More informationHIV Risk Behaviour in Irish Intravenous Drug Users
Abstract HIV Risk Behaviour in Irish Intravenous Drug Users A. Dorman, E. Keenan, C. Schuttler, J. Merry, J. J. O Connor The Drug Treatment Centre Board, Trinity Court, 30/31 Pearse Street, Dublin 2. The
More informationHepatitis prevention in the context of HIV prevention point work in Latvia
Hepatitis prevention in the context of HIV prevention point work in Latvia Līva Grāmatiņa Centre for disease prevention and control of Latvia 9..205. HIV prevention point network in Latvia: History; Location;
More informationPrevention services for minors in prisons
Prevention services for minors in prisons Iulia-Veronica Broasca Project Manager, ARAS-Romanian Association Against-AIDS Issues Up to 10% of all new HIV infections worldwide are attributed to injecting
More informationDr Vivian Hope. Health Protection Agency, London. 19 th Annual Conference of the British HIV Association (BHIVA)
19 th Annual Conference of the British HIV Association (BHIVA) Dr Vivian Hope Health Protection Agency, London 16-19 April 2013, Manchester Central Convention Complex Prevalence of, and risk factors for,
More informationPrEP Home Checklist v1.0
PrEP Home Checklist v1.0 Every Visit o Risk Reduction Counseling o Appropriate referrals and follow-ups (SW, Pharmacy, et al.) o For those on PrEP: o Assessment of PrEP adherence, side effects, ongoing
More informationBackground Past Present Future
Background Past Present Future Background Early testing helps to prevent transmission and lowers the risk of severe health complications Programatic objective: To increase the percentage of HIV + persons
More informationGovernment of Canada Federal AIDS Initiative Milestones
HIV in Canada: Trends and Issues for Advancing Prevention, Care, Treatment and Support Through Knowledge Exchange Michael R Smith, Senior Policy Advisor, Programs and Coordination Division, Centre for
More informationThe Integrated Bio Behavioural Surveillance (IBBS) Survey 2009 Malaysia: Preliminary Findings
The Integrated Bio Behavioural Surveillance (IBBS) Survey 2009 Malaysia: Preliminary Findings INES YAP Director of Evaluation and Development Malaysian AIDS Council Malaysia HIV Roundtable Discussion,
More informationM. Vall-Mayans a, *, M. Villa b, M. Saravanya a, E. Loureiro a, M. Meroño c, E. Arellano a, B. Sanz a, P. Saladié a, A. Andreu b, M.G.
International Journal of Infectious Diseases (2007) 11, 115 122 http://intl.elsevierhealth.com/journals/ijid Sexually transmitted Chlamydia trachomatis, Neisseria gonorrhoeae, and HIV-1 infections in two
More informationSigns of success latest national NESI data?
Needle Exchange Surveillance Initiative Signs of success latest national NESI data? Alison Munro (University of the West of Scotland) Study partners Professor Avril Taylor Chief Investigator (UWS) Dr Alison
More informationPrevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs
Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs Aljona Kurbatova National Institute for Health Development Estonia Estimated number of people who inject
More informationDrug using mothers: retaining care of their children
Drug using mothers: factors associated with retaining care of their children Gail Gilchrist 1 and Avril Taylor 2 1 L'Institut Municipal d'investigació Mèdica, Barcelona, Spain p g,, p 2 University of the
More informationMethods: respondent driven sampling (RDS) was used to recruit PWID
RDS study among PWID in Kohtla-Järve, north-east of Estonia: prevalence of HIV and risk behaviours (an update, based on 216 study, and methodological considerations) Maris Salekešin Sigrid Vorobjov Methods:
More informationSexual relationships, risk behaviour, and condom
368 Original article Department of Genitourinary Medicine, Charing Cross Hospital, Fulham Palace Road, London W6 8RF B A Evans Charing Cross and Westminster Medical School, Charing Cross Hospital, London
More informationPlease note: If you filled in the form during a previous visit, you must not fill it in again!
Appendix: Åse Haugstvedt, Eirik Amundsen, Rigmor C. Berg. Chemsex among men a questionnaire study. Tidsskriftet (Journal of the Norwegian Medical Association) 2018; 138. doi: 10.4045/tidsskr.18.0108 This
More informationFirst results collected by Argos, DCR in Strasbourg opened in november 2016
Photo Marine Saiah First results collected by Argos, DCR in Strasbourg opened in november 2016 Danièle BADER, Leader of Ithaque Association EMCDDA, DRID Meeting 18-20 september 2017 A crossborder experimentation
More informationYoung People and HIV/AIDS
Young People and HIV/AIDS Fact Sheet Young People at the Centre of HIV/AIDS Epidemic The fourth most populous country in the world with an estimated population of. million, Indonesia has 3% of its total
More informationI TRACK Survey. Report June 1, 2006
I TRACK Survey Enhanced Surveillance of Risk Behaviours and Prevalence of HIV and Hepatitis C Among People Who Inject Drugs Report June 1, 2006 Prepared by: Epidemiology and Disease Control and Population
More informationAs a result of this training, participants will be able to:
Addressing Sexual Risk with Drug Users and their Partners 1 Day Training This one-day training will build participant knowledge and skills in offering sexual harm reduction options to substance users.
More informationAustralian Research Centre in Sex, Health & Society. EMBARGOED until am 4/8/09 Secondary Students and Sexual Health 2008
Australian Research Centre in Sex, Health & Society EMBARGOED until 10.30 am 4/8/09 Secondary Students and Sexual Health 2008 Melbourne, Australia Sample 2002 2008 Jurisdictions All All School sectors
More informationGay Community Periodic Survey: Canberra 2015
Gay Community Periodic Survey: Canberra 05 Never Stand Still Art Social Sciences Centre for Social Research in Health Peter Hull Limin Mao Keiran Rossteuscher Stephanie Marion-Landais Philippa Moss Garrett
More informationNational HIV Behavioral Surveillance Portland, Oregon
National HIV Behavioral Surveillance Portland, Oregon Tim W. Menza, MD, PhD Medical Director HIV/STD/TB Section Oregon Health Authority timothy.w.menza@state.or.us National HIV Behavioral Surveillance
More informationGay Community Periodic Survey: Melbourne 2017
Arts Social Sciences Centre for Social Research in Health Gay Community Periodic Survey: Melbourne 07 Centre for Social Research in Health Victorian AIDS Council Living Positive Victoria Department of
More informationAnnual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use
Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use Report of the Government of: Reporting Year: Completed on (date): Please return completed questionnaire to: arq@unodc.org
More informationDr. dr. Diah Setia Utami, SpKJ, MARS Deputy of Rehabilitation Narcotic National Board of Republic of Indonesia
Dr. dr. Diah Setia Utami, SpKJ, MARS Deputy of Rehabilitation Narcotic National Board of Republic of Indonesia Growing evidence in changing of usage, from natural plant substances to synthetic substances
More informationEMCDDA-update HIV/HCV among people who inject drugs: situation and response
EMCDDA-update HIV/HCV among people who inject drugs: situation and response Dagmar Hedrich EU Think Tank HIV/AIDS: 24-25 November 2015, Luxembourg Latest European overview Multi-indicator based analysis
More informationSexually Transmitted Infections in Vulnerable Groups. Kevin Rebe
Sexually Transmitted Infections in Vulnerable Groups Kevin Rebe Definition: Key Populations Key populations are: Defined groups who, due to specific higher-risk behaviours, are at increased Men risk who
More informationTHE REPUBLIC OF BELARUS
THE REPUBLIC OF BELARUS National Report on the Follow-up to the UNGASS Declaration of Commitment on HIV/AIDS Reporting period: January 2003 December 2005 Minsk 2005 TABLE OF CONTENTS 1. Situation at a
More informationSummary Report - IBBS Balochistan - Quetta Round 1, ROUND 1 SUMMARY REPORT -BALOCHISTAN QUETTA
ROUND 1, 5-6 SUMMARY REPORT - BALOCHISTAN NATIONAL AIDS CONTROL PROGRAM BALOCHISTAN AIDS CONTROL PROGRAM CANADA PAKISTAN HIV/AIDS SURVEILLANCE PROJECT May 6 5-6 ROUND 1 SUMMARY REPORT -BALOCHISTAN QUETTA
More informationFrom Fix to Foil. The Dutch experience in promoting transition away from injecting drug use,
From Fix to Foil The Dutch experience in promoting transition away from injecting drug use, 1991-2009 International Harm Reduction Conference Liverpool, April 2010 John-Peter Kools Contents 1. Dutch context
More informationMethadone Treatment as a Harm Reduction Strategy, Gender Sensitive Programming and Evidence-based Strategies
Methadone Treatment as a Harm Reduction Strategy, Gender Sensitive Programming and Evidence-based Strategies Wendee Wechsberg, PhD, Senior Director Substance Abuse Treatment Evaluations and Interventions
More informationThe Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC
The Comprehensive Package: The simple truth about our response to drug related HIV Dr. Monica Beg, Signe Rotberga UNODC HIV among injecting drug users Why is it so important? 30% global HIV infections
More informationThe role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009
The role of UNODC in working law enforcement agencies to promote harm reduction IHRC, Bangkok, 23 April 2009 Drug control has focused mostly on law enforcement Public health which is the first principle
More informationGay Community Periodic Survey Canberra 2011
Gay Community Periodic Survey Canberra 0 Never Stand Still Faculty of Arts and Social Sciences National Centre in HIV Social Research Peter Hull Limin Mao Keiran Rossteuscher Garrett Prestage Iryna Zablotska
More informationSouth Asian Cocktail The Predominant Drug Use Pattern in Nepal and its Association with Spread of HIV
14 Original Article South Asian Cocktail The Predominant Drug Use Pattern in Nepal and its Association with Spread of HIV Ojha S P 1, Sigdel S 2, H-G M 3, Verthein U 4 1 Tribhuvan University Teaching Hospital,
More informationNew South Wales Needle and Syringe Program Enhanced Data Collection
New South Wales Needle and Syringe Program Enhanced Data Collection 2017 A report for the NSW Ministry of Health by the Kirby Institute, UNSW Australia August 2017 Prepared by Ms Louise Geddes, Dr Jenny
More informationUNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision
UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision Updated version following MERG recommendations Context In light of country reports, regional workshops and comments received by a
More informationCOUNTRY TABLE. MONTENEGRO.
EPIDEMIOLOGICAL DATA Indicator Data Source of data/additional notes re data Year of estimate Population 620 029 National Census data 2011 Estimated number of people who inject drugs (PWID) 1282 (95%CI
More informationINTRAVENOUS INJECTING DRUG USE.
Injecting drug users in Europe Towards an educational approach Lucas Wiessing European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon lucas.wiessing@ emcdda.org www.emcdda.org It has been
More informationWHITEHORSE I-TRACK REPORT. Monitoring Risk Behaviour among People Who Inject or Inhale Drugs in Whitehorse, Yukon
WHITEHORSE I-TRACK REPORT Monitoring Risk Behaviour among People Who Inject or Inhale Drugs in Whitehorse, Yukon : Monitoring Risk Behaviour among People Who Inject or Inhale Drugs in Whitehorse, Yukon
More informationFormative Research results
FRR Annex 5: Presentation of the FR results in the project meeting, Berlin, 11. 13.02.2013 Formative Research results Sandra Dudareva Vizule, Ulrich Marcus Robert Koch Institute 11 February 2013 Content
More informationPart of the Continuum of Care. Harm Reduction. Gino Vumbaca President Harm Reduction Australia
Part of the Continuum of Care Harm Reduction Gino Vumbaca President Harm Reduction Australia What is Harm Reduction The defining features are the focus on the reduction of harm, rather than on the prevention
More informationUpdate Report # 45. Patterns of Sexual Behaviors and Sexual Risk among HIV Positive People in New York City
Update Report # 45 Patterns of Sexual Behaviors and Sexual Risk among HIV Positive People in New York City Angela A. Aidala Mary Ann Chiasson Gunjeong Lee Center for Applied Public Health Joseph L. Mailman
More informationChina Country Advocacy Brief Injecting Drug Use and HIV
United Nations Regional Task Force on Injecting Drug Use and HIV/AIDS for Asia and the Pacific China Country Advocacy Brief Injecting Drug Use and HIV Key actions to be supported Expansion of the national
More informationPromoting hepatitis B vaccination
Promoting hepatitis B vaccination Introduction Hepatitis B is a serious blood borne infection that can exacerbate hepatitis C infection, can cause serious liver damage and sometimes results in death. Hepatitis
More informationTechnical Guidance Note for Global Fund HIV Proposals
Technical Guidance Note for Global Fund HIV Proposals UNAIDS I World Health Organization I 2011 Rationale for including this activity in the proposal The World Health Organization (WHO), the Joint United
More informationGay Community Periodic Survey: Perth 2016
Gay Community Periodic Survey: Perth 06 Never Stand Still Art Social Sciences Centre for Social Research in Health Evelyn Lee Limin Mao Matt Creamer Sue Laing Jude Comfort Garrett Prestage Iryna Zablotska
More informationBlood-borne viruses in marginalised populations
Blood-borne viruses in marginalised populations 2 May 2014 SYDNEY MEDICAL SCHOOL Bethany White, PhD Discipline of Addiction Medicine Overview Blood-borne viruses: HIV Hepatitis B virus (HBV) Hepatitis
More informationStrategies to Reduce Harm and HIV/AIDS Infection among Drug Using Populations
cessation of use may be the most effective form of harm reduction but, in reality, many clients do not wish to cease using, or find it too difficult. (Addy & Ritter, 2000, p.1) Introduction Historically,
More informationHarm Reduction in Nigeria
Harm Reduction in Nigeria Needs, gaps, and responses to ensure access to effective HIV prevention, treatment and care for people who inject drugs February 2018 This document is made possible by the generous
More informationCo-Variation in Sexual and Non-Sexual Risk Behaviors Over Time Among U.S. High School Students:
Co-Variation in Sexual and Non-Sexual Risk Behaviors Over Time Among U.S. High School Students: 1991-2005 John Santelli, MD, MPH, Marion Carter, PhD, Patricia Dittus, PhD, Mark Orr, PhD APHA 135 th Annual
More informationOverview of Syringe Exchange Programs. New York City Police Academy November 24, 2004
Overview of Syringe Exchange Programs New York City Police Academy November 24, 2004 History of Syringe Exchange n Title 10 N.Y.C.R.R. 80.131 (a) (2), 80.135. n Enacted in 1992 in response to the HIV/AIDS
More information2 nd Meeting on detecting and responding to outbreaks of HIV among PWID
2 nd Meeting on detecting and responding to outbreaks of HIV among PWID Update on country situation: ROMANIA Adrian Abagiu* & Andrei Botescu** *Romanian Association Against AIDS (ARAS) and National Institute
More informationAs a result of this training, participants will be able to:
Addressing Prevention with HIV Positive Clients 1 Day Training This one-day training will prepare participants to help people living with HIV to avoid sexual and substance use behaviors that can result
More informationHIV EPIDEMIC UPDATE: FACTS & FIGURES 2012
HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012 Number of Cases Note: In this surveillance report, HIV cases include persons reported with HIV infection (non-aids), advanced HIV (non-aids) and AIDS within a
More informationCONFERENCES CYCLE IN ENGLISH (1 st edition) Dr. Elisabet Vilella Pharmacogenomics and Genetics Unitat de Recerca. Hospital Pere Mata.
(1 st edition) January 28 th, 2002 Dr. Elisabet Vilella Pharmacogenomics and Genetics Unitat de Recerca. Hospital Pere Mata. February 4 th, 2002 Dr. Manuel Mas-Bagà Therapeutic community and dual diagnosis
More informationDetection of Hepatitis B and C in Primary Care
Detection of Hepatitis B and C in Primary Care Presentation 2 January 2016 Quality Quality Education Education for for aa Healthier Healthier Scotland Scotland 1 1 Learning Outcomes Participants will be
More informationPrevention and care towards vulnerable and stigmatized populations (MSM, drug users, sex workers)
Prevention and care towards vulnerable and stigmatized populations (MSM, drug users, sex workers) Joseph LARMARANGE - CEPED/IRD Symposium ANRS - AIDS 2012-23 July 2012 Epidemiological context» South America
More informationSTIs and BBVs. The facts
EASY ENGLISH STIs and BBVs Some people say sex germs The facts New words There may be words in this factsheet that are new to you and you may not know what they mean or you may be unsure what they mean.
More informationGlossary of Acronyms. AIDS - Acquired Immunodeficiency Syndrome. CDC - Centers for Disease Control and Prevention. DHS - Department of Health Services
Acknowledgements This report was developed by the California Department of Health Services, Office of AIDS (DHS/OA) under cooperative agreement. U6/CCU965-- with support from the Centers for Disease Control
More informationUNGASS Indicators and possible adoption of NDPHS indicators. Tallinn /P.Leinikki
UNGASS Indicators and possible adoption of NDPHS indicators National Indicators 1. Committment and Action: 1. Domestic and international AIDS spending by categories and financing sources 2. National Composite
More informationSurvey questionnaire on STI. surveillance, care and prevention. in European countries SAMPLE APPENDIX
European Surveillance of Sexually Transmitted Infections Survey questionnaire on STI surveillance, care and prevention in European countries APPENDIX Detailed questionnaire on clinician and laboratory
More informationHIV/AIDS Prevalence Among South African Health Workers, 2002
HIV/AIDS Prevalence Among South African Health Workers, 2002 Presented at the Kwazulu/Natal INDABA on AIDS 2 December 2003 O. Shisana, Sc.D Executive Director, SAHA Human Sciences Research Council Introduction
More informationReview on HIV & Associated Infections in Latvia
Review on HIV & Associated Infections in Latvia Dr.Inga Upmace, Infectology Center of Latvia Second meeting on EG on HIV/AIDS and AI April 7, 2011, Riga Negative influences: Several reorganizations of
More informationHIV/AIDS INDICATORS. AIDS Indicator Survey 8 Basic Documentation Introduction to the AIS
HIV/AIDS INDICATORS During the last decade there has been an increased effort to track the progress in the area of HIV/AIDS. A of international agencies and organizations have developed indicators designed
More informationDrug consumption among roma population
NATIONAL ANTIDRUG AGENCY Drug consumption among roma population High risk drug use and drug treatment in Europe 2014 Special populations and drug problems Lisbon, 24 September 2014 General characteristics
More informationCharacteristics of cases of infectious syphilis diagnosed in prisons,
34 Rev Esp Sanid Penit 2011; 13: 52-57 Characteristics of cases of infectious syphilis diagnosed in prisons, 2007-2008 C Garriga 1, 3, P Gómez-Pintado 2, M Díez 1, 3, E Acín 2, A Díaz 1, 3 1 Department
More informationUNAIDS 99.1E (English original, March 1999) This document, presenting a speech given at the United Nations General Assembly Special Session on Drugs,
U N A I D S B E S T P R A C T I C E C O L L E C T I O N Drug use and HIV/AIDS UNAIDS statement presented at the United Nations General Assembly Special Session on Drugs Joint United Nations Programme on
More informationKey words: YIDUs, condom use behaviour
Extended Absract Sexual risk behaviour among young injecting drug users in high HIV prevalence states of India: Evidence from IBBA Santosh Kumar Sharma (Ph.D. Scholor) International Institute for Poulation
More informationSexually Transmitted Infection, including HIV, Health Protection Scotland Slide Set
Sexually Transmitted Infection, including HIV, 213 Health Protection Scotland Slide Set Enhanced surveillance systems are employed to give more detailed information on the epidemiology of infectious syphilis
More informationDEPARTMENT OF HEALTH RESPONSE TO KEY POPULATIONS
DEPARTMENT OF HEALTH RESPONSE TO KEY POPULATIONS KEY POPULATIONS PREVENTION INTERVENTIONS Ms E Marumo HIV PREVENTION STRATEGIES 13 June 2017 1 Background SA has about 7.1 million people living with HIV
More informationAUSTRALIAN NSP SURVEY
AUSTRALIAN NSP SURVEY Prevalence of HIV, HCV and injecting and sexual behaviour among Needle and Syringe Program attendees 20 YEAR NATIONAL DATA REPORT 1995-2014 Report prepared by Jenny Iversen and Lisa
More informationGlobal AIDS Response Progress Report Myanmar. National AIDS Programme
Global AIDS Response Progress Report Myanmar National AIDS Programme Reporting period: January 2014 December 2014 Submission date: 15 June 2015 Table of Contents 1. Status at a glance... 6 1.1 Reporting
More information59 th Session of Commission on Narcotic Drugs Vienna 14-22March 2016
59 th Session of Commission on Narcotic Drugs Vienna 14-22March 2016 Accepted resolution to take to UNGASS 19-21 April We reiterate our commitment to end by 2030 the epidemics of AIDS and tuberculosis,
More informationTesting, Prevention and Care IDU in Chicago, 2009
HIV/HCV Risk Behaviors, Testing, Prevention and Care IDU in Chicago, 2009 Nik Prachand Britt Livak HIV Behavioral Surveillance IDU2 Cycle Surveillance, Epidemiology and Research Division of STI/HIV/AIDS
More informationGroups of young people in Uganda that need to be targeted with HIV interventions
Module 5: HIV/AIDS and young people - Adolescent health and development with a particular focus on sexual and reproductive health - Assignment Peter James Ibembe Reproductive Health Uganda, Kampala, Uganda
More informationNarrative report of HIV Preventive programmes in the Slovak Republic as of 31-st December 2013
Narrative report of HIV Preventive programmes in the Slovak Republic as of 31-st December 2013 1. Introduction HIV/AIDS pandemic is a human, social and economic disaster, with far-reaching implications
More informationResponsibilities in a sexual relationship - Contact tracing
P a g e 1 Responsibilities in a sexual relationship - Contact tracing This activity has been designed increase student familiarity with the NSW Health Play Safe website. Suggested duration: 50-60 minutes
More informationU.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs
U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs Michelle Van Handel, MPH Health Scientist National Center for HIV/AIDS, Viral Hepatitis, STDs and
More information